ACTIVE SUBSTANCE / INN

TEZEPELUMAB

Brand name(s): Tezspire
EMA LISTED
AUTHORISED
Asthma;Sinusitis
ACTIVE SUBSTANCE
Tezepelumab
REGULATORS
EMA
SPONSORS / MAH
AstraZeneca AB
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TezspireAstraZeneca ABAuthorised19/09/2022Asthma;Sinusitis

FULL INTELLIGENCE ON TEZEPELUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →